Showing results (531-540 of 557) with videos related to

Sort By:
Pageof 56
Dystonia (Lausanne, Switzerland)|October 17, 2022
Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature ReviewLaura M Scorr, Hyun Joo Cho, Gamze Kilic-Berkmen, et al.
Neuron|March 31, 2026
Large-scale CSF and plasma proteomics reveal immune, synaptic, and extracellular matrix disruptions across neurodegenerative diseasesMuhammad Ali, Jigyasha Timsina, Ying Xu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 19, 2016
Clinical and demographic characteristics related to onset site and spread of cervical dystoniaScott A Norris, H A Jinnah, Alberto J Espay, et al.
European Journal of Neurology|July 23, 2021
Predictive modeling of spread in adult-onset isolated dystonia: Key properties and effect of tremor inclusionMeng Wang, Tolulope Sajobi, Francesca Morgante, et al.
Neurology|December 10, 2003
A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD studyS Karamohamed, A L DeStefano, J B Wilk, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 21, 2005
Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD studySamer Karamohamed, L I Golbe, M H Mark, et al.
Brain : a Journal of Neurology|November 7, 2022
Mitochondrial haplogroups and cognitive progression in Parkinson's diseaseGanqiang Liu, Chunming Ni, Jiamin Zhan, et al.
Neurology|December 14, 2005
BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD StudyS Karamohamed, J C Latourelle, B A Racette, et al.
Archives of Neurology|June 14, 2006
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD studyMei Sun, Jeanne C Latourelle, G Frederick Wooten, et al.
Nature Aging|May 20, 2025
Large-scale plasma proteomic profiling unveils diagnostic biomarkers and pathways for Alzheimer's diseaseGyujin Heo, Ying Xu, Erming Wang, et al.
Pageof 56